Dr. Luis Soruco, M.D
NPI: 1013065556
Total Payments
$130,203
2022 Payments
$13.59
Companies
45
Transactions
588
Medicare Patients
466
Medicare Billing
$35,535
Payment Breakdown by Category
Other$105,027 (80.7%)
Consulting$10,735 (8.2%)
Food & Beverage$9,792 (7.5%)
Travel$2,735 (2.1%)
Research$1,897 (1.5%)
Education$17.18 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $105,027 | 68 | 80.7% |
| Consulting Fee | $10,735 | 7 | 8.2% |
| Food and Beverage | $9,792 | 487 | 7.5% |
| Travel and Lodging | $2,735 | 9 | 2.1% |
| Unspecified | $1,897 | 14 | 1.5% |
| Education | $17.18 | 3 | 0.0% |
Payments by Type
General
$128,305
574 transactions
Research
$1,897
14 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $51,171 | 87 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $47,838 | 126 | $0 (2020) |
| Lilly USA, LLC | $24,738 | 61 | $0 (2020) |
| SANOFI US SERVICES INC. | $1,897 | 14 | $0 (2019) |
| Novo Nordisk Inc | $820.10 | 52 | $0 (2020) |
| Shire North American Group Inc | $381.11 | 20 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $355.88 | 25 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $312.86 | 28 | $0 (2020) |
| Amgen Inc. | $283.42 | 17 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $251.58 | 19 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $13.59 | 1 | Abbott Laboratories ($13.59) |
| 2020 | $11,237 | 38 | Lilly USA, LLC ($8,217) |
| 2019 | $16,414 | 174 | Lilly USA, LLC ($12,173) |
| 2018 | $40,318 | 180 | Boehringer Ingelheim Pharmaceuticals, Inc. ($24,089) |
| 2017 | $62,220 | 195 | SANOFI-AVENTIS U.S. LLC ($38,019) |
All Payment Transactions
588 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/22/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: Diabetes Care | ||||||
| 08/24/2020 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: Hyperparathyroidism | ||||||
| 08/18/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| Category: DIABETES | ||||||
| 07/07/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS, Tresiba | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Diabetes | ||||||
| 07/01/2020 | Abbott Laboratories | FreeStyle Libre (Device) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Diabetes Care | ||||||
| 06/30/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/18/2020 | RECORDATI_RARE_DISEASES_INC. | — | Food and Beverage | Cash or cash equivalent | $16.64 | General |
| 03/11/2020 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,300.00 | General |
| Category: Diabetes | ||||||
| 03/11/2020 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $500.00 | General |
| Category: Diabetes | ||||||
| 03/09/2020 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: Diabetes | ||||||
| 03/09/2020 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $0.49 | General |
| Category: Diabetes | ||||||
| 03/05/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), GLYXAMBI | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: DIABETES | ||||||
| 03/03/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.06 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/02/2020 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Diabetes | ||||||
| 02/27/2020 | Abbott Laboratories | FreeStyle Libre (Device) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: Diabetes Care | ||||||
| 02/26/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Endocrinology | ||||||
| 02/25/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Endocrinology | ||||||
| 02/24/2020 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,300.00 | General |
| Category: Diabetes | ||||||
| 02/24/2020 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $500.00 | General |
| Category: Diabetes | ||||||
| 02/24/2020 | Alexion Pharmaceuticals, Inc. | Strensiq (Drug) | Food and Beverage | In-kind items and services | $29.97 | General |
| Category: Endocrinology | ||||||
| 02/20/2020 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,762.50 | General |
| Category: Diabetes | ||||||
| 02/19/2020 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Diabetes | ||||||
| 02/06/2020 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,300.00 | General |
| Category: Diabetes | ||||||
| 02/06/2020 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $500.00 | General |
| Category: Diabetes | ||||||
| 02/06/2020 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $11.61 | General |
| Category: DIABETES MEDICINE | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Effect of Efpeglenatide on Cardiovascular Outcomes in Type 2 Diabetes Patients at High Cardiovascular | SANOFI US SERVICES INC. | $1,019 | 7 |
| Randomized, Open Label, Parallel-group Study Comparing the Pharmacokinetics and Immunogenicity of Alternating Use of SAR341402 and NovoLog? Versus Continuous Use of NovoLog in Participants With Type | SANOFI US SERVICES INC. | $878.40 | 7 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 89 | 100 | $26,462 | $5,813 |
| 2021 | 1 | 33 | 33 | $8,687 | $2,531 |
| 2020 | 4 | 344 | 434 | $67,496 | $27,191 |
Total Patients
466
Total Services
567
Medicare Billing
$35,535
Procedure Codes
6
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 89 | 100 | $26,462 | $5,813 | 22.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 33 | 33 | $8,687 | $2,531 | 29.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 233 | 262 | $47,160 | $14,449 | 30.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 41 | 102 | $11,016 | $6,241 | 56.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 50 | 50 | $5,500 | $4,151 | 75.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 20 | 20 | $3,820 | $2,350 | 61.5% |
About Dr. Luis Soruco, M.D
Dr. Luis Soruco, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Arlington Heights, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/08/2007. The National Provider Identifier (NPI) number assigned to this provider is 1013065556.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Luis Soruco, M.D has received a total of $130,203 in payments from pharmaceutical and medical device companies, with $13.59 received in 2022. These payments were reported across 588 transactions from 45 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($105,027).
As a Medicare-enrolled provider, Soruco has provided services to 466 Medicare beneficiaries, totaling 567 services with total Medicare billing of $35,535. Data is available for 3 years (2020–2022), covering 6 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Arlington Heights, IL
- Active Since 01/08/2007
- Last Updated 06/11/2012
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1013065556
Products in Payments
- JARDIANCE (Drug) $71,852
- SOLIQUA (Drug) $35,708
- TOUJEO (Drug) $10,969
- SOTAGLIFLOZIN (Drug) $4,233
- SAR439977 (Drug) $1,019
- SAR341402 (Drug) $878.40
- TRADJENTA (Drug) $445.20
- FARXIGA (Drug) $336.37
- Victoza (Drug) $274.62
- Minimed 670G System (Device) $245.46
- JANUVIA (Drug) $218.22
- Ozempic (Drug) $216.52
- INVOKANA (Drug) $210.56
- Saxenda (Drug) $184.74
- NATPARA (Drug) $173.26
- AFREZZA (Drug) $165.73
- FreeStyle Libre (Device) $153.78
- HUMULIN (Drug) $133.67
- Prolia (Biological) $119.58
- Dexcom CGM (Device) $115.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Arlington Heights
Dr. Daniel So, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $431,029
Endocrinology, Diabetes & Metabolism $431,029
Dr. Mario Chan, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $31,415
Endocrinology, Diabetes & Metabolism $31,415
Paraskevi Sapountzi, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $19,168
Endocrinology, Diabetes & Metabolism $19,168
Zubair Ilyas, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $12,208
Endocrinology, Diabetes & Metabolism $12,208
Elena Barengolts
Endocrinology, Diabetes & Metabolism — Payments: $7,748
Endocrinology, Diabetes & Metabolism $7,748
Maria Justina Villano, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $971.90
Endocrinology, Diabetes & Metabolism $971.90